About
Kevin Kinsella founded Avalon in 1983. He has specialized in the formation, financing and/or development of more than 60 early-stage companies, including: Athena Neurosciences (acquired by Elan Corporation, plc (NYSE: ELN)); Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX); Sequana Therapeutics (merged with Arris to form AXYS Pharmaceuticals, acquired by Celera Genomics (NYSE: CRA)); Vertex Pharmaceuticals, Inc. (Nasdaq: VRTX); Synaptics, Inc. (Nasdaq: SYNA); Vocera Communications; and Sytera Ophthalmics Inc. (acquired by Sirion Therapeutics). Mr. Kinsella was the founding chairman of Athena Neurosciences, Aurora Biosciences Corporation, Landmark Graphics, NeoRx, Onyx Pharmaceuticals, Inc., Synaptics, Vertex Pharmaceuticals, X-Ceptor and Sequana Therapeutics. Prior to founding Avalon, Mr. Kinsella worked for Solar Turbines International (Caterpillar Tractor) where he was in charge of all international joint ventures, barter and counter-trade. Previously, he was an advisor to the Peruvian gov
Position in the VCSift Database
- • 5 investors at Avalon Ventures are tracked.
- • 1,303 investors hold the Managing Partner role in VCSift. Kevin Kinsella is one of them.
- • 53 investors are based in La Jolla, California, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- La Jolla, US
Contact Information
Find more investors like Kevin
Search Investors